ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,113 Cr | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,113 Cr |
| Mar2025 | ₹881 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹285 Cr |
| Mar2022 | ₹269 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,113 Cr | 26.34 | |
| Mar2025 | ₹881 Cr | 860.69 | |
| Mar2024 | ₹92 Cr | -67.77 | |
| Mar2023 | ₹285 Cr | 5.93 | |
| Mar2022 | ₹269 Cr | - | |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹60,398.0 Cr | 2.6% | -2.3% | -8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 2.6% |
-2.3% |
-8.3% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses